Riganti C - Search Results

1

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.

Kopecka J, Salaroglio IC, Righi L, Libener R, Orecchia S, Grosso F, Milosevic V, Ananthanarayanan P, Ricci L, Capelletto E, Pradotto M, Napoli F, Di Maio M, Novello S, Rubinstein M, Scagliotti GV, Riganti C. Kopecka J, et al. Among authors: riganti c. Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26. Lung Cancer. 2018. PMID: 29748013 Free article.

2

Simian virus 40 infection down-regulates the expression of nitric oxide synthase in human mesothelial cells.

Aldieri E, Orecchia S, Ghigo D, Bergandi L, Riganti C, Fubini B, Betta PG, Bosia A. Aldieri E, et al. Among authors: riganti c. Cancer Res. 2004 Jun 15;64(12):4082-4. doi: 10.1158/0008-5472.CAN-04-0486. Cancer Res. 2004. PMID: 15205315

3

Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.

Riganti C, Orecchia S, Pescarmona G, Betta PG, Ghigo D, Bosia A. Riganti C, et al. Int J Cancer. 2006 Jul 1;119(1):17-27. doi: 10.1002/ijc.21832. Int J Cancer. 2006. PMID: 16450390 Free article.

4

Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition.

Riganti C, Orecchia S, Silvagno F, Pescarmona G, Betta PG, Gazzano E, Aldieri E, Ghigo D, Bosia A. Riganti C, et al. Am J Respir Cell Mol Biol. 2007 Jun;36(6):746-56. doi: 10.1165/rcmb.2006-0011OC. Epub 2007 Feb 22. Am J Respir Cell Mol Biol. 2007. PMID: 17322126

5

Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.

Riganti C, Doublier S, Aldieri E, Orecchia S, Betta PG, Gazzano E, Ghigo D, Bosia A. Riganti C, et al. Eur Respir J. 2008 Aug;32(2):443-51. doi: 10.1183/09031936.00090407. Epub 2008 Apr 2. Eur Respir J. 2008. PMID: 18385176 Free article.

6

iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.

De Boo S, Kopecka J, Brusa D, Gazzano E, Matera L, Ghigo D, Bosia A, Riganti C. De Boo S, et al. Among authors: riganti c. Mol Cancer. 2009 Nov 19;8:108. doi: 10.1186/1476-4598-8-108. Mol Cancer. 2009. PMID: 19925669 Free PMC article.

7

Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells.

Kopecka J, Campia I, Brusa D, Doublier S, Matera L, Ghigo D, Bosia A, Riganti C. Kopecka J, et al. Among authors: riganti c. J Cell Mol Med. 2011 Jul;15(7):1492-504. doi: 10.1111/j.1582-4934.2010.01137.x. J Cell Mol Med. 2011. PMID: 20716130 Free PMC article.

8

A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells.

Kopecka J, Campia I, Olivero P, Pescarmona G, Ghigo D, Bosia A, Riganti C. Kopecka J, et al. Among authors: riganti c. J Control Release. 2011 Jan 20;149(2):196-205. doi: 10.1016/j.jconrel.2010.10.003. Epub 2010 Oct 12. J Control Release. 2011. PMID: 20946921

9

Pleiotropic effects of cardioactive glycosides.

Riganti C, Campia I, Kopecka J, Gazzano E, Doublier S, Aldieri E, Bosia A, Ghigo D. Riganti C, et al. Curr Med Chem. 2011;18(6):872-85. doi: 10.2174/092986711794927685. Curr Med Chem. 2011. PMID: 21182478 Review.

10

Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells.

Aldieri E, Riganti C, Silvagno F, Orecchia S, Betta PG, Doublier S, Gazzano E, Polimeni M, Bosia A, Ghigo D. Aldieri E, et al. Among authors: riganti c. Am J Respir Cell Mol Biol. 2011 Sep;45(3):625-31. doi: 10.1165/rcmb.2010-0089OC. Epub 2011 Jan 21. Am J Respir Cell Mol Biol. 2011. PMID: 21257924 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page